Summitry LLC’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$588K Buy
+23,352
New +$588K 0.02% 145
2025
Q3
Sell
-1,053,450
Closed -$26.6M 225
2025
Q2
$26.6M Buy
1,053,450
+199,667
+23% +$4.95M 1.21% 33
2025
Q1
$21.3M Buy
853,783
+40,076
+5% +$991K 1.08% 33
2024
Q4
$20M Sell
813,707
-188,981
-19% -$4.73M 0.98% 33
2024
Q3
$25.8M Buy
1,002,688
+10,262
+1% +$259K 1.23% 30
2024
Q2
$24.4M Sell
992,426
-315,361
-24% -$7.7M 1.26% 29
2024
Q1
$32.4M Buy
1,307,787
+47,661
+4% +$1.18M 1.7% 26
2023
Q4
$31.8M Buy
+1,260,126
New +$30.1M 1.85% 26

Other funds holding IBDX

Summitry LLC's IBDX Position: Q2 2026 in Review

Summitry LLC opened a new position in iShares iBonds Dec 2032 Term Corporate ETF (IBDX) in Q2 2026: 23,352 shares worth $588K. The stake represents 0.02% of the portfolio and ranks #145 among its holdings. This is a return to the name: Summitry LLC previously reported a position in IBDX as recently as Q2 2025.

Summitry LLC first reported a position in IBDX in Q4 2023 and has held it in 8 quarters since. The position peaked at $32.4M in Q1 2024. 228 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.

  • Summitry LLC held 23,352 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $588K as of Q2 2026.
  • iShares iBonds Dec 2032 Term Corporate ETF was a new Summitry LLC position in Q2 2026.
  • iShares iBonds Dec 2032 Term Corporate ETF made up 0.02% of Summitry LLC's portfolio in Q2 2026, its #145 holding.
  • Summitry LLC first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q4 2023 and has held it in 8 quarters since.
  • Summitry LLC's iShares iBonds Dec 2032 Term Corporate ETF position peaked at $32.4M in Q1 2024.
  • 228 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.

Based on Summitry LLC's 13F filing for Q2 2026, filed 21 Jul 2026.